Rekvina Laboratories P/B Ratio
Current P/B Ratio
20.92
High Valuation
Very High - Significant premium, high growth expectations or speculative
Rekvina Laboratories P/B ratio. Rekvina Laboratories (VINRKLB) P/B ratio is 20.92 (High), book value per share ₹-3.33 vs Healthcare average P/B of -0.3 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see Rekvina Laboratories screener.
Current Valuation Metrics
P/B Ratio
20.92
Current Price
₹80.17
Book Value/Share
₹-3.33
Exchange
BSE
Book Value Breakdown (2026)
Balance Sheet Components
Total Equity
₹-1 Cr
Share Capital
₹3 Cr
Reserves & Surplus
₹-4 Cr
Outstanding Shares
3,000,000
Book Value per Share
₹-3.33
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
-0.3
Sector Median
0.39
Sector Rank
#11 of 50
Sector Percentile
22.0%
VINRKLB P/B Ratio — Valuation Insights & Book Value Analysis
Rekvina Laboratories price-to-book ratio interpretation, valuation status and historical context — current P/B 20.92 (High). Read VINRKLB ex-dividend dates for the complete payout history and dividend yield track record.
- Stock appears overvalued with PB of 20.92, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Trading at premium to sector average PB of -0.3
VINRKLB vs Healthcare Peers — P/B Ratio Comparison
Rekvina Laboratories P/B 20.92 vs Healthcare average -0.3, median 0.39 — range -7.62–0.89.
Sector Average
-0.3
Sector Median
0.39
Lowest P/B
-7.62
Highest P/B
0.89
Companies
50
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Chennai Meenakshi Multis… | CMMHOSP | -7.62 | ₹27 | Low |
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -1.2 | ₹39 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.75 | ₹128 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.18 | ₹43 | Low |